Hansa Biopharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsHansa Biopharma

Hansa Biopharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Idefirix	Imlifidase	2020-08-25		Kidney transplantation , Immunologic desensitization

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

alzheimer disease

,

macular degeneration

,

hepatic insufficiency

,

cognitive dysfunction

,

precursor cell lymphoblastic leukemia-lymphoma

,

maximum tolerated dose

,

antineoplastic protocols

,

pharmacokinetics

,

myeloproliferative disorders

,

type 1 diabetes mellitus

,

,

acquired immunodeficiency syndrome

,

,

,

immunologic deficiency syndromes

,

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

adenocarcinoma of lung

,

hematologic neoplasms

,

biliary liver cirrhosis

,

neonatal anemia

,

peripheral nervous system diseases

,

,

critical illness

,

gastrointestinal diseases

,

hidradenitis suppurativa

,

,

chronic hepatitis b

,

,

,

,

,

,

,

diffuse intrinsic pontine glioma

,

optic nerve glioma

,

brain stem neoplasms

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

pathologic complete response

,

,

sexually transmitted diseases

,

retroviridae infections

,

viral sexually transmitted diseases

,

pancreatic neoplasms

,

triple negative breast neoplasms

,

sickle cell anemia

,

immunoglobulin light-chain amyloidosis

,

healthy volunteers/patients

,

multiple myeloma

,

prostatic neoplasms

,

non-small-cell lung carcinoma

,

plasma cell neoplasms

,

large b-cell lymphoma diffuse

,

orthopedic procedures

,

rheumatoid arthritis

,

b-cell lymphoma

,

chronic renal insufficiency

,

blood transfusion

,

non-hodgkin lymphoma

,

psoriatic arthritis

,

,

mantle-cell lymphoma

,

kidney diseases

,

chronic kidney failure

,

systemic lupus erythematosus

,

follicular lymphoma

,

b-cell chronic lymphocytic leukemia

,

myelodysplastic syndromes

,

breast neoplasms

,

autologous blood transfusion

,

diabetes mellitus

,

,

ankylosing spondylitis

,

ovarian neoplasms

,

axial spondyloarthritis

,

,

lymphoid leukemia

,

renal insufficiency

,

,

neoplasm metastasis

,

cardiovascular surgical procedures

,

cerebrospinal fluid leak

,

peripheral vascular diseases

,

respiratory syncytial viruses

,

juvenile arthritis

,

waldenstrom macroglobulinemia

,

colorectal neoplasms

,

b-cell lymphoma marginal zone

,

,

,

retinal diseases

,

esophageal neoplasms

,

small cell lung carcinoma

,

,

venous thrombosis

,

stomach neoplasms

,

rectal neoplasms

,

,

diabetic neuropathies

,

,

,

ebola hemorrhagic fever

,

soft tissue injuries

,

surgical blood loss

,

neurologic manifestations

,

respiratory tract diseases

,

,

kidney transplantation

,

neonatal alloimmune thrombocytopenia

,

,

,

,

,

,

,

ulcerative colitis

,

,

type 2 diabetes mellitus

,

inflammatory bowel diseases

,

cardiovascular diseases

,

,

atrial fibrillation

,

metabolic syndrome

,

pure red-cell aplasia

,

postoperative pain

,

abdominal hernia

,

retinal diseases

,

kidney diseases

,

chronic renal insufficiency

,

type 2 diabetes mellitus

,

diabetes mellitus

,

chronic kidney failure

,

,

renal insufficiency

,

,

chronic hepatitis c

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use